Kiang-Teck Jerry Yeo to Cytochrome P-450 CYP2D6
This is a "connection" page, showing publications Kiang-Teck Jerry Yeo has written about Cytochrome P-450 CYP2D6.
Connection Strength
0.553
-
Validation of a CYP2D6 genotyping panel on the NanoChip Molecular Biology Workstation. Clin Chem. 2007 May; 53(5):823-8.
Score: 0.292
-
Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project. J Mol Diagn. 2010 Nov; 12(6):835-46.
Score: 0.093
-
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clin Chim Acta. 2006 May; 367(1-2):196-200.
Score: 0.067
-
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer. 2022 Apr 15; 128(8):1649-1657.
Score: 0.051
-
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. Oncologist. 2021 11; 26(11):e2042-e2052.
Score: 0.050